MarkNtel Advisors – Leading Market Research Company found Global Plasma Fractionation Market is expected to reach 7.1% CAGR Growth By 2030.
This report provides a comprehensive analysis of the Global Plasma Fractionation Market, with a focus on market size, segmentation, key players, geographical analysis, and growth in the coming years. The expert team of analysts invested considerable time and effort in collecting and analyzing the latest market data, producing a comprehensive and current report that provides valuable insights for decision-makers, including business owners and analysts.
Comprehensive Analysis of the Plasma Fractionation Market
Base Year: 2023
Forecast Years: 2024-2030
Historical Years: 2019-2022
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
If you’re interested in the assumptions considered in this study, you can download the PDF brochure- - https://www.marknteladvisors.com/query/request-sample/plasma-fractionation-market.html
Scope of the Plasma Fractionation Market Report:
The Global Plasma Fractionation Market is estimated to grow at a CAGR of around 7.1% during the forecast period, i.e., 2024-30. The demand for plasma-derived therapy has been increasing worldwide, owing to the prevalence of rare disorders in the global population. In 2023, according to the Rare Disease Day Organization, around 300 million people worldwide are living with a rare disorder.
Which prominent factor is expected to drive the Plasma Fractionation Market during 2024-30?
Escalating Geriatric Population Driving the Demand for Plasma-derived Therapies – Globally, the surging geriatric population has resulted in a substantial boost in the incidences of diseases like immunodeficiency, neurological disorders, etc., which require plasma-derived therapies for treatment. The increment in the geriatric population has been attributed to the increasing life expectancy of the elderly population in various countries like China, Japan, etc., as a result of their improved healthcare infrastructure. Consequently, as the number of geriatric patients has been increasing, there has been an enhanced demand for plasma-derived therapeutic products, particularly immunoglobulins and coagulation factors during historical years.
Further, in response to this growing demand on a global scale, companies specializing in plasma fractionation have proactively started investing in expanding their plasma therapy manufacturing facilities. Such strategic initiatives by companies across the world position them to better address the increasing need for improved treatment, ultimately contributing to positive growth of the Plasma Fractionation Market.
What are the different Segment Available in the Plasma Fractionation Market?
By Product
- Immunoglobulin- Market Size & Forecast 2019-2030, (USD Million)
- Intravenous Immunoglobulin- Market Size & Forecast 2019-2030, (USD Million)
- Subcutaneous Immunoglobulin- Market Size & Forecast 2019-2030, (USD Million)
- Other Disease Specific Immunoglobulins (Hepatitis B Immunoglobulin, Tetanus Immunoglobulin, etc.) - Market Size & Forecast 2019-2030, (USD Million)
- Coagulation Factors- Market Size & Forecast 2019-2030, (USD Million)
- Factor VIII- Market Size & Forecast 2019-2030, (USD Million)
- Factor IX- Market Size & Forecast 2019-2030, (USD Million)
- Von Willebrand Factor (vWF) - Market Size & Forecast 2019-2030, (USD Million)
- Prothrombin Complex Concentrates- Market Size & Forecast 2019-2030, (USD Million)
- Fibrinogen Concentrates- Market Size & Forecast 2019-2030, (USD Million)
- Factor XIII- Market Size & Forecast 2019-2030, (USD Million)
- Others (Factor VIIa, Factor XI, etc.)- Market Size & Forecast 2019-2030, (USD Million)
- Albumin- Market Size & Forecast 2019-2030, (USD Million)
- Protease Inhibitor- Market Size & Forecast 2019-2030, (USD Million)
- Others (Plasminogen, Antithrombin III, etc.) - Market Size & Forecast 2019-2030, (USD Million)
By Application
- Neurology- Market Size & Forecast 2019-2030, (USD Million)
- Immunology- Market Size & Forecast 2019-2030, (USD Million)
- Hematology- Market Size & Forecast 2019-2030, (USD Million)
- Critical Care- Market Size & Forecast 2019-2030, (USD Million)
- Pulmonology- Market Size & Forecast 2019-2030, (USD Million)
- Rheumatology- Market Size & Forecast 2019-2030, (USD Million)
- Others (Oncology, Pediatrics, etc.) - Market Size & Forecast 2019-2030, (USD Million)
By End User
- Hospitals - Market Size & Forecast 2019-2030, (USD Million)
- Specialty Clinics- Market Size & Forecast 2019-2030, (USD Million)
- Research Facilities - Market Size & Forecast 2019-2030, (USD Million)
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific.
Browse Full Report Along with TOC and Figures - https://www.marknteladvisors.com/research-library/plasma-fractionation-market.html
Leading Plasma Fractionation companies operating in the Market
- Biotest A.G.
- Octapharma A.G.
- Adma Biologics
- Aegros
- CSL Limited
- Grifols S.A.
- Kedrion Biopharma Inc.
- Bio Products Laboratory Ltd
- Takeda Pharmaceuticals
- Emergent Bio solutions
- Intas Pharmaceutical
- Plasma Gen Biosciences
- S K Plasma
- Australian Red Cross Lifeblood
- Others.
*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
Other Report:
- https://www.whatech.com/og/markets-research/food-beverage/894935-wine-market-rising-trends-opportunities-and-challenges-growth-at-a-cagr-of-4-64-by-2030.html
- https://www.whatech.com/og/markets-research/food-beverage/894924-cheese-market-to-witness-5-85-cagr-growth-between-2024-and-2030.html
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Call +1 628 895 8081 +91 120 4278433
Email: sales@marknteladvisors.com
Comments (0)